EP0990657B1
(en)
*
|
1998-04-03 |
2003-09-03 |
Nippon Shokubai Co., Ltd. |
Process for producing fine organometallic particles and catalyst for polymerization
|
WO2000077072A1
(en)
*
|
1999-06-11 |
2000-12-21 |
The Procter & Gamble Company |
Soluble polyfunctional initiators for lactone ring-opening polymerization
|
CN1234769C
(zh)
|
2000-09-12 |
2006-01-04 |
联合碳化化学及塑料技术公司 |
含有烯化氧共聚物的聚合物复合材料
|
CA2483656C
(en)
*
|
2002-04-29 |
2013-06-18 |
Alza Corporation |
Reduced formate poly(alkylene oxide) for a controlled release dosage form of reboxetine
|
US7776314B2
(en)
|
2002-06-17 |
2010-08-17 |
Grunenthal Gmbh |
Abuse-proofed dosage system
|
DE10361596A1
(de)
*
|
2003-12-24 |
2005-09-29 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
ES2407143T3
(es)
*
|
2003-08-06 |
2013-06-11 |
Grünenthal GmbH |
Forma de dosificación protegida contra un posible abuso
|
US8075872B2
(en)
|
2003-08-06 |
2011-12-13 |
Gruenenthal Gmbh |
Abuse-proofed dosage form
|
DE102005005446A1
(de)
*
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Bruchfeste Darreichungsformen mit retardierter Freisetzung
|
DE102004020220A1
(de)
*
|
2004-04-22 |
2005-11-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
DE10336400A1
(de)
*
|
2003-08-06 |
2005-03-24 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
US20070048228A1
(en)
|
2003-08-06 |
2007-03-01 |
Elisabeth Arkenau-Maric |
Abuse-proofed dosage form
|
DE102004032049A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
DE102004032103A1
(de)
*
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
EP1797183B1
(en)
*
|
2004-09-02 |
2012-08-01 |
Yale University |
Regulation of oncogenes by micrornas
|
DE102005005449A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
US8354384B2
(en)
*
|
2005-06-23 |
2013-01-15 |
Yale University |
Anti-aging micrornas
|
US8658608B2
(en)
*
|
2005-11-23 |
2014-02-25 |
Yale University |
Modified triple-helix forming oligonucleotides for targeted mutagenesis
|
US7645616B2
(en)
*
|
2006-10-20 |
2010-01-12 |
The University Of Hong Kong |
Use of lipocalin-2 as a diagnostic marker and therapeutic target
|
JP2010515464A
(ja)
*
|
2007-01-11 |
2010-05-13 |
イエール・ユニバーシテイ |
Hiv細胞表面受容体の標的化不活性化のための組成物および方法
|
DE102007011485A1
(de)
|
2007-03-07 |
2008-09-11 |
Grünenthal GmbH |
Darreichungsform mit erschwertem Missbrauch
|
WO2008116216A1
(en)
*
|
2007-03-22 |
2008-09-25 |
Medical College Of Georgia Research Institute, Inc. |
Compositions and methods for inhibiting cancer metastasis
|
US8383152B2
(en)
|
2008-01-25 |
2013-02-26 |
Gruenenthal Gmbh |
Pharmaceutical dosage form
|
JP2011515078A
(ja)
*
|
2008-03-01 |
2011-05-19 |
アブラクシス バイオサイエンス リミテッド ライアビリティー カンパニー |
SPARC特異的miRNAを使用する、治療、診断、及び拮抗物質発見方法
|
JP2011519951A
(ja)
*
|
2008-05-07 |
2011-07-14 |
アブラクシス バイオサイエンス リミテッド ライアビリティー カンパニー |
miRNAによる薬物治療の増強
|
HUE030803T2
(en)
|
2008-05-09 |
2017-06-28 |
Gruenenthal Gmbh |
Process for the preparation of an intermediate powder formulation and a final solid dosage form using a spraying step \ t
|
US9056944B2
(en)
*
|
2009-02-11 |
2015-06-16 |
Dow Global Technologies Llc |
Ductile polymer binders and battery components using the same
|
US8309356B2
(en)
*
|
2009-04-01 |
2012-11-13 |
Yale University |
Pseudocomplementary oligonucleotides for targeted gene therapy
|
CA2765971C
(en)
*
|
2009-07-22 |
2017-08-22 |
Gruenenthal Gmbh |
Hot-melt extruded controlled release dosage form
|
CA2766172C
(en)
|
2009-07-22 |
2017-09-12 |
Lutz Barnscheid |
Oxidation-stabilized tamper-resistant dosage form
|
EP2287304A1
(en)
|
2009-08-17 |
2011-02-23 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Novel treatment of patients after stent implantation or balloon dilatation and novel drug eluting stents
|
EP2531176B1
(en)
|
2010-02-03 |
2016-09-07 |
Grünenthal GmbH |
Preparation of a powdery pharmaceutical composition by means of an extruder
|
WO2011133803A1
(en)
|
2010-04-21 |
2011-10-27 |
Helix Therapeutics, Inc. |
Compositions and methods for targeted inactivation of hiv cell surface receptors
|
WO2011133802A1
(en)
|
2010-04-21 |
2011-10-27 |
Helix Therapeutics, Inc. |
Compositions and methods for treatment of lysosomal storage disorders
|
BR112013005194A2
(pt)
|
2010-09-02 |
2016-05-03 |
Gruenenthal Gmbh |
forma de dosagem resistente à violação compreendendo sal inorgânico
|
JP5933553B2
(ja)
|
2010-09-02 |
2016-06-15 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
アニオン性ポリマーを含む不正使用抵抗性剤形
|
US8459326B2
(en)
*
|
2011-01-06 |
2013-06-11 |
Hunter Douglas, Inc. |
Cellular shade assembly and method for constructing same
|
CA2826043A1
(en)
|
2011-02-03 |
2012-08-09 |
Mirna Therapeutics, Inc. |
Synthetic mimics of mir-124
|
WO2012106591A1
(en)
|
2011-02-03 |
2012-08-09 |
Mirna Therapeutics, Inc. |
Synthetic mimics of mir-34
|
CN103562266B
(zh)
*
|
2011-06-03 |
2016-01-20 |
住友精化株式会社 |
聚环氧烷粒子及其制造方法
|
KR101871539B1
(ko)
*
|
2011-06-03 |
2018-06-26 |
스미토모 세이카 가부시키가이샤 |
폴리알킬렌옥시드 입자 및 그의 제조방법
|
PE20141638A1
(es)
|
2011-07-29 |
2014-11-22 |
Gruenenthal Chemie |
Tableta a prueba de manipulacion que proporciona liberacion de farmaco inmediato
|
EP2736497B1
(en)
|
2011-07-29 |
2017-08-23 |
Grünenthal GmbH |
Tamper-resistant tablet providing immediate drug release
|
EP2739734A1
(en)
|
2011-08-03 |
2014-06-11 |
The Charlotte-Mecklenburg Hospital Authority d/b/a Carolina Healthcare System |
Treatment of fibrosis using microrna-19b
|
MX356421B
(es)
|
2012-02-28 |
2018-05-29 |
Gruenenthal Gmbh |
Forma de dosificacion resistente a la manipulacion indebida que comprende un compuesto farmacologicamente activo y un polimero anionico.
|
JP6282261B2
(ja)
|
2012-04-18 |
2018-02-21 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
不正使用防止および過量放出防止医薬剤形
|
US10064945B2
(en)
|
2012-05-11 |
2018-09-04 |
Gruenenthal Gmbh |
Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
|
ES2650945T3
(es)
|
2012-05-11 |
2018-01-23 |
Grünenthal GmbH |
Forma de dosificación farmacéutica termoconformada resistente a la manipulación que contiene zinc
|
WO2014093726A1
(en)
|
2012-12-12 |
2014-06-19 |
The Charlotte-Mecklenburg Hospital Authority D/B/A Carolinas Healthcare System |
Methods of treating portal hypertension
|
EP2931272A1
(en)
|
2012-12-12 |
2015-10-21 |
The Charlotte-Mecklenburg Hospital Authority D/B/A Carolinas Healthcare System |
Methods of treating hepatic fibrosis and associated diseases by regulating rev-erb activity
|
WO2014191397A1
(en)
|
2013-05-29 |
2014-12-04 |
Grünenthal GmbH |
Tamper-resistant dosage form containing one or more particles
|
MX2015016254A
(es)
|
2013-05-29 |
2016-04-20 |
Gruenenthal Gmbh |
Forma de dosificacion resistente al uso indebido con perfil de liberacion bimodal.
|
CN105682643B
(zh)
|
2013-07-12 |
2019-12-13 |
格吕伦塔尔有限公司 |
含有乙烯-醋酸乙烯酯聚合物的防篡改剂型
|
EP3071627B1
(en)
|
2013-11-22 |
2018-01-31 |
Dow Global Technologies LLC |
Zinc catalyst / additive system for the polymerization of epoxide monomers
|
WO2015077210A1
(en)
|
2013-11-22 |
2015-05-28 |
Dow Global Technologies Llc |
Zinc catalyst / additive system for the polymerization of epoxide monomers
|
CN105705551B
(zh)
*
|
2013-11-22 |
2017-04-19 |
陶氏环球技术有限责任公司 |
用于环氧化物单体聚合的锌催化剂/添加剂***
|
MX371372B
(es)
|
2013-11-26 |
2020-01-28 |
Gruenenthal Gmbh |
Preparacion de una composicion farmaceutica en polvo por medio de criomolienda.
|
CA2946162A1
(en)
|
2014-04-30 |
2015-11-05 |
Dow Global Technologies Llc |
Treatment of aqueous mineral suspensions with polymeric flocculants
|
WO2015168378A1
(en)
|
2014-04-30 |
2015-11-05 |
Dow Global Technologies Llc |
Polymeric flocculants for treating aqueous mineral suspensions
|
ES2966886T3
(es)
|
2014-05-09 |
2024-04-24 |
Univ Yale |
Partículas recubiertas con poliglicerol hiperramificado y métodos de elaboración y uso de las mismas
|
US11918695B2
(en)
|
2014-05-09 |
2024-03-05 |
Yale University |
Topical formulation of hyperbranched polymer-coated particles
|
US20150320690A1
(en)
|
2014-05-12 |
2015-11-12 |
Grünenthal GmbH |
Tamper resistant immediate release capsule formulation comprising tapentadol
|
WO2015181059A1
(en)
|
2014-05-26 |
2015-12-03 |
Grünenthal GmbH |
Multiparticles safeguarded against ethanolic dose-dumping
|
US20170216791A1
(en)
|
2014-07-31 |
2017-08-03 |
Dow Global Technologies Llc |
In-line dynamic mixing apparatus for flocculating and dewatering oil sands fine tailings
|
MX2017013637A
(es)
|
2015-04-24 |
2018-03-08 |
Gruenenthal Gmbh |
Forma de dosificacion resistente a alteraciones con liberacion inmediata y resistencia contra la extraccion por solventes.
|
US10781117B2
(en)
|
2015-08-25 |
2020-09-22 |
Dow Global Technologies Llc |
Flocculation of high-solids mineral slurries
|
JP2018526414A
(ja)
|
2015-09-10 |
2018-09-13 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
乱用抑止性の即放性製剤を用いた経口過剰摂取に対する保護
|
WO2017143042A2
(en)
|
2016-02-16 |
2017-08-24 |
Yale University |
Compositions for enhancing targeted gene editing and methods of use thereof
|
CA3014795A1
(en)
|
2016-02-16 |
2017-08-24 |
Yale University |
Compositions and methods for treatment of cystic fibrosis
|
AR108480A1
(es)
|
2016-05-27 |
2018-08-22 |
Dow Global Technologies Llc |
Método de tratamiento de suspensiones minerales con alto contenido de sólidos con floculantes poliméricos
|
WO2017207623A1
(en)
|
2016-05-31 |
2017-12-07 |
Université de Lausanne |
Mirna as biomarkers and regulators of cancer stem cells
|
US20190322643A1
(en)
|
2016-06-29 |
2019-10-24 |
Georgia State University Research Foundation, Inc. |
Histone deacetylase and histone methyltransferase inhibitors and methods of making and use of the same
|
CA3038070A1
(en)
|
2016-09-23 |
2018-03-29 |
Dow Global Technologies Llc |
Process for tailings remediation
|
US20210371316A1
(en)
|
2016-09-27 |
2021-12-02 |
Dow Global Technologies Llc |
Process for dewatering an aqueous process stream
|
WO2018080746A1
(en)
|
2016-10-31 |
2018-05-03 |
Dow Global Technologies Llc |
Online analysis of oil sands tailings content
|
US20200113821A1
(en)
|
2017-04-04 |
2020-04-16 |
Yale University |
Compositions and methods for in utero delivery
|
CA3078827A1
(en)
|
2017-10-13 |
2019-04-18 |
Dow Global Technologies Llc |
Method to improve tailings flowability for pipeline transport
|
WO2019154884A1
(en)
|
2018-02-07 |
2019-08-15 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Method for determining cancer invasiveness and patient prognosis
|
JP2022512739A
(ja)
|
2018-10-19 |
2022-02-07 |
ボード オブ リージェンツ,ザ ユニバーシティ オブ テキサス システム |
操作された長鎖散在反復エレメント(line)トランスポゾンおよびそれらの使用方法
|
EP3677693A1
(en)
|
2019-01-03 |
2020-07-08 |
Ecole Polytechnique Federale De Lausanne (EPFL) EPFL-TTO |
Transpochimeric gene trancripts (tcgts) as cancer biomarkers
|
WO2020257779A1
(en)
|
2019-06-21 |
2020-12-24 |
Yale University |
Hydroxymethyl-modified gamma-pna compositions and methods of use thereof
|
WO2020257776A1
(en)
|
2019-06-21 |
2020-12-24 |
Yale University |
Peptide nucleic acid compositions with modified hoogsteen binding segments and methods of use thereof
|
WO2021022161A1
(en)
|
2019-07-31 |
2021-02-04 |
Yale University |
Compositions and methods for treating sickle cell disease
|
WO2022237974A1
(en)
|
2021-05-12 |
2022-11-17 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Krab-containing zinc finger protein and cancer
|
EP4352226A1
(en)
|
2021-06-07 |
2024-04-17 |
Yale University |
Peptide nucleic acids for spatiotemporal control of crispr-cas binding
|